PKSI-527 is a new, highly selective plasma kallikrein inhibitor . PKSI-527 can suppress collagen-induced arthritis (CIA) by modifying the kallikrein-kinin system.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Kallikrein
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。